| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA658338 | B | Binding affinity against human coagulation factor X | 33 | single protein format | Scientific Literature | |||
| 2. | ALA764412 | B | Inhibition of Human Serine Protease Plasmin | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 3. | ALA814319 | B | Activity against Human Serine Protease Thrombin | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 4. | ALA824709 | B | Activity against Human Serine Protease Trypsin | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 5. | ALA847817 | B | Inhibition of Human Serine Protease tissue type Plasminogen Activator | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 6. | ALA842146 | B | Inhibitory concentration against Human Serine Protease Urokinase Plasminogen Activator | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 7. | ALA869020 | B | Binding affinity to F9a | Homo sapiens | 4 | single protein format | Scientific Literature | ||
| 8. | ALA869021 | F | Anticoagulant potency in human plasma as measured by activated partial thromboplastin time | Homo sapiens | 2 | cell-free format | Scientific Literature | ||
| 9. | ALA869022 | F | Anticoagulant potency in human plasma as measured by prothrombin time | Homo sapiens | 2 | cell-free format | Scientific Literature | ||
| 10. | ALA869023 | B | Selectivity for F9a over thrombin | 4 | assay format | Scientific Literature | |||
| 11. | ALA869024 | B | Selectivity for F9a over F7a | Homo sapiens | 4 | assay format | Scientific Literature | ||
| 12. | ALA869025 | B | Selectivity for F9a over F10a | Homo sapiens | 4 | protein format | Scientific Literature | ||
| 13. | ALA858906 | B | Selectivity for F9a over trypsin | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 14. | ALA3301366 | A | ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound. | Rattus norvegicus | 717 | cell-free format | AstraZeneca Deposited Data |
The page will load shortly, Thanks for your patience!